Chestnut Hill Healthcare   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Philadelphia PA United States (1975)

Organization Overview

First Clinical Trial
2006
NCT00365742
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Chestnut Hill Health System

Active Ingredients

Drugs in Phase 3 Trials (2)

cholesterol (4 trials)

phytosterol (1 trial)

Drugs in Phase 2 Trials (1)

pravastatin (pravachol) (1 trial)

Drugs in Other Trials (2)

fish oil (Omegavan) (1 trial)

simvastatin (zocor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypercholesterolemia (Phase 2)

Hyperlipidemias (Phase 3)

Hyperlipoproteinemias (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 5